Purpose: To develop a high resolution microarray based method to detect single- and multiexons gene deletions and duplications. Methods: We have developed a high-resolution comparative genomic ...

Clinical testing using various array comparative genomic hybridization platforms is being incorporated rapidly into cytogenetic testing algorithms. Comprehensive validation of these complex assays ...

infoQuant Ltd brings microarray technology closer to clinical use with its latest release of copy number analysis and interpretation software "oneClickCGH" and "CGH Fusion" for microarray-based ...

計測機器大手Agilent Technologiesの日本法人であるアジレント・テクノロジーは2月12日、ベイラー医科大学 遺伝医学研究所と ...

In addition to the surprising revelation that our chromosomes harbor fewer genes than originally predicted, the Human Genome Project also unveiled that all individuals share approximately 99.9% of ...

Microarray based comparative genomic hybridisation (array CGH) is a new technology with uses developing in various diagnostic areas within the NHS. One important context is the investigation of ...

Agilent Technologiesの日本法人であるアジレント・テクノロジーは、ガン研究者や疾病と遺伝的要素の関連解析、高度医療における新しい分子診断法の開発を行っている研究者向けに第3世代マイクロアレイ「SurePrint G3 マイクロアレイ」を発表、4月1日からの販売 ...

Array comparative genomic hybridization (CGH) is illuminating DNA copy number variations (CNV) throughout the genome to diagnose disease etiology and to help tailor treatment regimens for patients to ...